BangladeshTaevas Global acts as your authorized local representative before the Directorate General of Drug Administration, giving medical devices manufacturers a compliant, credible, and commercially ready presence in Bangladesh from day one.
Our Legal Representation service for Medical Devices in Bangladesh is built on six interconnected pillars that together ensure regulatory compliance, market readiness, and long-term commercial success.
Taevas Global serves as your officially designated local agent under the Drugs Act 1940 and DGDA's medical device import and registration framework. We hold the legal authority to correspond with DGDA on your behalf, sign regulatory submissions, and receive official communications. This removes the need for you to establish a physical entity in Bangladesh before your products are market-ready.
Our four-stage engagement model takes you from initial scoping through to full regulatory activation and commercial readiness in Bangladesh.
We begin with a structured intake session to understand your device portfolio, existing international registrations, and target segments in Bangladesh. Our regulatory team reviews your device classifications, intended use, and any existing WHO PQ or CE/FDA clearances that can support a faster DGDA pathway. You receive a written scoping memo outlining the regulatory route, estimated timeline, and required documentation.
The scoping session covers device risk classification under DGDA's framework, identification of applicable technical standards, a gap analysis of your existing technical file against DGDA requirements, and a preliminary timeline with milestone dates. This memo becomes the project charter for the entire engagement.
Bangladesh's Directorate General of Drug Administration is actively developing a dedicated medical device regulatory framework separate from its pharmaceutical regulations. The government has signaled alignment with IMDRF guidelines, meaning companies that establish compliant registrations now will benefit from grandfather provisions as the new framework is formalized. Early movers gain a significant regulatory head start over competitors who delay entry.
Bangladesh imports over 90 percent of its medical devices, making the import permit and DGDA registration process the primary gatekeeping mechanism for market access. Non-compliant imports are subject to seizure, fines, and blacklisting of the importer, which can permanently damage your brand's commercial prospects. A qualified local legal representative eliminates this compliance risk entirely.
The private healthcare sector in Bangladesh has expanded rapidly, with major diagnostic chains and private hospital groups in Dhaka, Chittagong, and Sylhet investing heavily in diagnostic imaging, surgical equipment, and patient monitoring technology. This sector operates on commercial procurement cycles and responds well to internationally registered, brand-supported medical devices. It represents the fastest route to initial revenue for new market entrants.
The Government of Bangladesh procures medical devices through the Central Medical Stores Department and Health Engineering Department for public hospitals and upazila health complexes. Participation in government tenders requires a locally registered product and a DGDA-licensed importer or authorized representative. Taevas Global's legal representation service directly enables your eligibility for this substantial and growing procurement channel.
Every Legal Representation engagement for Medical Devices in Bangladesh includes these eight structured deliverables, ensuring complete regulatory coverage and commercial readiness.
A written analysis of the applicable DGDA registration pathway for each device in your portfolio, including classification, required documentation, and estimated timeline.
A fully prepared and reviewed technical dossier compiled to DGDA specifications, ready for formal submission including all required certificates, labeling, and product documentation.
Legally executed authorization documents designating Taevas Global as your official local agent before DGDA, filed and acknowledged by the authority.
Preparation and submission of import permit applications for each registered device, including annual renewal management and customs documentation support.
A complete, auditable record of all official communications with DGDA, including query letters, responses, meeting notes, and approval notifications.
A structured calendar of all regulatory renewal dates, post-market reporting obligations, and labeling review milestones for your Bangladesh device portfolio.
Ongoing monitoring of DGDA circulars, gazette notifications, and policy updates with proactive written alerts and recommended actions whenever changes affect your registered devices.
A structured handover briefing for your commercial, logistics, and distribution teams covering DGDA compliance obligations, labeling requirements, and import documentation standards.
You manufacture medical devices in Europe, the US, or Asia and have identified Bangladesh as a priority emerging market, but you have no local entity, no DGDA relationships, and no in-country regulatory expertise. You need a credible, accountable local representative who can navigate DGDA on your behalf and get your products to market without the cost and delay of establishing a subsidiary. Taevas Global becomes your regulatory and commercial anchor in Bangladesh from day one.
Speak with a Taevas Global regulatory specialist today to understand exactly what it takes to register your medical devices with DGDA and activate your Bangladesh market entry compliantly and efficiently.